Novel Enyne-Modified 1,4-Thiazepines as Epidermal Growth Factor Receptor Inhibitors: Anticancer and Computational Studies

Novel Enyne-Modified 1,4-Thiazepines as Epidermal Growth Factor Receptor Inhibitors: Anticancer and Computational Studies

Saved in:

Bibliographic Details
Main Authors:	Harika Atmaca, Çisil Çamlı Pulat, Suleyman Ilhan, Elif Serel Yilmaz, Metin Zora
Format:	Article
Language:	English
Published:	American Chemical Society 2024-12-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.4c07877
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

GC-MS Analysis and Potential Apoptotic Effect of Paliurus spina-christi Mill. Leaf and Flower Extracts against Breast Cancer Cells
by: Çisil Çamlı Pulat, et al.
Published: (2022-04-01)

Potential Anti-SARS-CoV-2 Effects of Gossypol and AT-101: Molecular Docking Study Against Angiotensin Converting Enzyme 2
by: Süleyman İlhan, et al.
Published: (2024-04-01)

Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors
by: Huang-Chih Chang, et al.
Published: (2017-03-01)

A novel epidermal growth factor receptor inhibitor for treating lung cancer
by: Jiansheng Gao, et al.
Published: (2017-03-01)

Antitumor effect of a new human epidermal growth factor receptor inhibitor
by: O. I. Kit, et al.
Published: (2024-09-01)

A Case of Competitive Aromatization vs. Sigmatropic [1,5]-Hydrogen Atom Migration in a 1,2,4-Cyclohexatriene Intermediate Derived from a Bis-Enyne Cyclization
by: Rong Tang, et al.
Published: (2025-06-01)

Caspase-14-like Proteases: An Epidermal Caspase and Its Evolutionarily Ancient Relatives
by: Leopold Eckhart, et al.
Published: (2025-06-01)

Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
by: K. Chanprapaph, et al.
Published: (2014-01-01)

Expression of human epidermal growth factor receptor 2 in meningiomas
by: Mazaher Ramezani, et al.
Published: (2020-01-01)

Molecular Docking Study: Application to the Epidermal Growth Factor Receptor
by: Faiza Asli, et al.
Published: (2024-11-01)

Cell Adhesion Molecules as Modulators of the Epidermal Growth Factor Receptor
by: Irina Kozlova, et al.
Published: (2024-11-01)

EGFRp4 Peptides: A Novel Strategy for Epidermal Growth Factor Receptor (EGFR) Inhibitor
by: Nattanan Jiwacharoenchai, et al.
Published: (2025-06-01)

Venom Peptides of Crotalus atrox Against SARS-Cov-2 Spike Protein and Human ACE2 Receptor by Molecular Docking Analysis
by: Süleyman İlhan
Published: (2023-08-01)

Near-infrared photoimmunotherapy for osteosarcoma targeting epidermal growth factor receptor
by: Motofumi Suzuki, et al.
Published: (2024-12-01)

Dermatologic adverse events associated with epidermal growth factor receptor inhibitors: current concepts of interdisciplinary problem
by: A. S. Polonskaia, et al.
Published: (2022-02-01)

Epidermal Nevi and Epidermal Naevus Syndromes
by: Gianluca Tadini, et al.
Published: (2025-08-01)

Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients
by: Yan-Jei Tang, et al.
Published: (2024-01-01)

The effects of anticancer drugs on levels of nitric oxide and adrenomedullin
by: Elif Güler, et al.
Published: (2006-07-01)

Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
by: Siyan Peng, et al.
Published: (2025-08-01)

Exploring the role of epidermal growth factor receptor variant III in meningeal tumors.
by: Rashmi Rana, et al.
Published: (2021-01-01)

Programmed death 1 inhibitor combined with radiotherapy decreases epidermal growth factor receptor expression in breast cancer
by: You Wu
Published: (2025-08-01)

Best evidence summary for preventing and preventing epidermal growth factor receptor inhibitors induced paronychia in cancer patients
by: Kexuan Li, et al.
Published: (2025-04-01)

Drug–drug interactions between epidermal growth factor receptor tyrosine kinase inhibitors and rivaroxaban in vitro and in vivo
by: Dongxu Wang, et al.
Published: (2025-01-01)

Nuclear Morphological Characteristics in Breast Cancer: Correlation with Hormone Receptor and Human Epidermal Growth Factor Receptor 2
by: Jiayu Li, et al.
Published: (2021-01-01)

Human epidermal growth factor receptor 2 expression and associated factors in endometrial carcinoma
by: Shiyun ZHANG, et al.
Published: (2025-06-01)

MOLECULAR DOCKING SIMULATIONS ON EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) WITH POTENTIAL LEAD MOLECULES
by: K Ganesh Kadiyala, et al.
Published: (2025-03-01)

A Premature Termination of Human Epidermal Growth Factor Receptor Transcription in Escherichia coli
by: Jihene Elloumi-Mseddi, et al.
Published: (2014-01-01)

Detection and significance of human epidermal growth factor receptor 2 expression in gastric adenocarcinoma
by: Sutapa Halder, et al.
Published: (2017-01-01)

Epidermal growth factor receptor signaling governs the host inflammatory response to invasive aspergillosis
by: Hong Liu, et al.
Published: (2024-12-01)

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
by: Sandra Rayego-Mateos, et al.
Published: (2018-01-01)

Protein expression, gene amplification, epidermal growth factor receptor mutations and lung carcinoma
by: Panjković Milana, et al.
Published: (2014-01-01)

Epidermal growth factor receptor contributes to indirect regulation of skeletal muscle mass by androgen
by: Tomoya Onishi, et al.
Published: (2025-03-01)

Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation
by: Yujing Wang, et al.
Published: (2024-12-01)

Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression
by: K. Morimoto, et al.
Published: (2025-06-01)

A prognostic signature for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer
by: Yincheng Liu, et al.
Published: (2025-07-01)

The root of Scutellaria baicalensis overcomes resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in H1975 cells
by: Hyun-Ji Park, et al.
Published: (2020-01-01)

Electrophysiological responsiveness and clinical outcomes of local corticosteroid injection in the treatment of carpal tunnel syndrome
by: Devrimsel Harika Ertem, et al.

Dopamine D2 receptor-mediated epidermal growth factor receptor signaling regulates neurogenesis in the subventricular zone of adult brain
by: Yea Jue Kim, et al.
Published: (2025-08-01)

Vitreoretinal Traction Syndrome, Nitrituria and Human Epidermal Growth Factor Receptor Negative Might Occur in the Aromatase-Inhibitor Anastrozole Treatment
by: Jie Li, et al.
Published: (2024-01-01)

Trastuzumab: A milestone in human epidermal growth factor receptor 2-positive breast cancer
by: Manikandan Dhanushkodi
Published: (2020-01-01)